UPDATE
Lilly Drug Investigated After US and German Deaths; Teva cleared in France
Eli Lilly's antipsychotic Zyprexa Relprevv is under investigation after reports of deaths in the US and Germany.
Archives for June 24, 2013
Private Equity Snatches PRA for $1.3B
Kohlberg Kravis Roberts (KKR) has purchased PRA International for $1.3B, which is about $500M more than previous private equity owner Genstar paid in 2007.
Western CMOs Hold Advantages Over East, says PTI
Cost of freight, customer service and regulatory compliance offer Western CMOs advantages over their Eastern Counterparts, according to US CMO Pharma Tech Industries (PTI).
3D Printing Could Create Better Pills say UK Researchers
3D printing could be used to optimize tablet designs and make drug delivery more effective according to UK additive manufacturing researchers.
Dispatches from DIA 2013
Parexel CEO: Growth Rate Slowing to Manageable Pace
Parexel’s growth rate has slowed recently to a pace that the company can more easily keep up with than in years past, CEO Josef von Rickenbach told us at DIA’s annual meeting in Boston on Monday.